• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝静脉压力梯度可预测肝硬化急性食管静脉曲张出血患者的进一步失代偿。

Hepatic Venous Pressure Gradient Predicts Further Decompensation in Cirrhosis Patients with Acute Esophageal Variceal Bleeding.

作者信息

Vaishnav Manas, Biswas Sagnik, Anand Abhinav, Pathak Piyush, Swaroop Shekhar, Aggarwal Arnav, Arora Umang, Elhence Anshuman, Gamanagatti Shivanand, Goel Amit, Kumar Ramesh

机构信息

Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi 110029, India.

Department of Radiology, All India Institute of Medical Sciences, New Delhi 110029, India.

出版信息

Diagnostics (Basel). 2023 Jul 16;13(14):2385. doi: 10.3390/diagnostics13142385.

DOI:10.3390/diagnostics13142385
PMID:37510129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10378396/
Abstract

BACKGROUND

The role of hepatic venous pressure gradient (HVPG) in predicting further decompensation in cirrhosis patients with acute variceal bleeding (AVB) is not known. We aimed to evaluate the role of HVPG in predicting further decompensation in cirrhosis patients with AVB Methods: In this prospective study, 145 patients with cirrhosis with esophageal or gastric AVB were included. HVPG was measured on the day of the AVB. Decompensating events occurring after 42-days of AVB were considered further decompensation.

RESULTS

The median age of the study cohort was 44 years; 88.3% males. The predominant etiology of cirrhosis was alcohol (46.2%). Overall, 40 (27.6%) patients developed further decompensation during median follow-up of 296 days following AVB. Gastro intestinal bleeding = 27 (18.6%) and new-onset/worsening ascites = 20 (13.8%) were the most common decompensating events. According to the multivariate model, HVPG was an independent predictor of any further decompensation in esophageal AVB patients but not in gastric variceal bleeding patients. HVPG cut-off of ≥16 mmHg predicted further decompensation in the esophageal AVB. However, HVPG was not an independent predictor of mortality.

CONCLUSION

HVPG measured during an episode of acute variceal hemorrhage from esophageal varices predicts further decompensating events in cirrhosis patients.

摘要

背景

肝静脉压力梯度(HVPG)在预测肝硬化急性静脉曲张出血(AVB)患者进一步失代偿中的作用尚不清楚。我们旨在评估HVPG在预测肝硬化AVB患者进一步失代偿中的作用。方法:在这项前瞻性研究中,纳入了145例患有食管或胃AVB的肝硬化患者。在AVB当天测量HVPG。将AVB 42天后发生的失代偿事件视为进一步失代偿。

结果

研究队列的中位年龄为44岁;男性占88.3%。肝硬化的主要病因是酒精(46.2%)。总体而言,在AVB后中位随访296天期间,40例(27.6%)患者发生了进一步失代偿。胃肠道出血=27例(18.6%)和新发/加重腹水=20例(13.8%)是最常见的失代偿事件。根据多变量模型,HVPG是食管AVB患者任何进一步失代偿的独立预测因素,但不是胃静脉曲张出血患者的独立预测因素。HVPG≥16 mmHg的临界值可预测食管AVB的进一步失代偿。然而,HVPG不是死亡率的独立预测因素。

结论

在食管静脉曲张急性曲张出血发作期间测量的HVPG可预测肝硬化患者的进一步失代偿事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8225/10378396/ea21c8c95c59/diagnostics-13-02385-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8225/10378396/96e1388ce4d5/diagnostics-13-02385-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8225/10378396/ea21c8c95c59/diagnostics-13-02385-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8225/10378396/96e1388ce4d5/diagnostics-13-02385-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8225/10378396/ea21c8c95c59/diagnostics-13-02385-g002.jpg

相似文献

1
Hepatic Venous Pressure Gradient Predicts Further Decompensation in Cirrhosis Patients with Acute Esophageal Variceal Bleeding.肝静脉压力梯度可预测肝硬化急性食管静脉曲张出血患者的进一步失代偿。
Diagnostics (Basel). 2023 Jul 16;13(14):2385. doi: 10.3390/diagnostics13142385.
2
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.肝静脉压力梯度可预测代偿期肝硬化患者的临床失代偿情况。
Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21.
3
An LSM Based Strategy is Comparable to HVPG Measurement to Predict Further Events in Patients with Cirrhosis with Variceal Bleeding as Their Index Decompensation.一种基于肝脏硬度测量(LSM)的策略在预测以静脉曲张出血为初始失代偿指标的肝硬化患者的进一步事件方面与肝静脉压力梯度(HVPG)测量相当。
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):774-782. doi: 10.1016/j.jceh.2023.04.008. Epub 2023 Apr 29.
4
Assessing the Risk of Further Decompensation and Survival in Patients With Cirrhosis With Variceal Bleeding as Their First Decompensation Event.评估以首次失代偿事件为静脉曲张出血的肝硬化患者进一步失代偿和生存的风险。
Am J Gastroenterol. 2023 May 1;118(5):833-839. doi: 10.14309/ajg.0000000000002018. Epub 2022 Sep 16.
5
Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy.药物及内镜治疗的急性静脉曲张出血患者的肝静脉压力梯度与预后
J Hepatol. 2008 Feb;48(2):229-36. doi: 10.1016/j.jhep.2007.10.008. Epub 2007 Nov 26.
6
A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCC.有静脉曲张出血史的 HCC 患者接受阿特珠单抗联合贝伐珠单抗治疗后会有进一步出血的风险。
Liver Int. 2022 Dec;42(12):2843-2854. doi: 10.1111/liv.15458. Epub 2022 Oct 26.
7
Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status.肝硬化患者的肝静脉压力梯度:与静脉曲张大小、出血、腹水及Child分级的相关性
Dig Dis Sci. 2006 Dec;51(12):2264-9. doi: 10.1007/s10620-006-9310-2. Epub 2006 Nov 1.
8
Correlation of hepatic venous pressure gradient with variceal bleeding, size of esophageal varices, etiology, ascites and degree of liver dysfunction in cirrhosis of liver.肝静脉压力梯度与肝硬化患者静脉曲张出血、食管静脉曲张大小、病因、腹水及肝功能障碍程度的相关性
Indian J Gastroenterol. 2009 Mar-Apr;28(2):59-61. doi: 10.1007/s12664-009-0019-y. Epub 2009 Aug 21.
9
The natural history of patients with compensated cirrhosis and elevated hepatic venous pressure gradient.代偿期肝硬化且肝静脉压力梯度升高患者的自然病史。
Portal Hypertens Cirrhosis. 2022 Sep;1(2):101-106. doi: 10.1002/poh2.27. Epub 2022 Sep 30.
10
Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.应用标准化的肝静脉压力梯度测量方案可提高读数质量,并有助于减少肝硬化患者的静脉曲张出血。
Singapore Med J. 2016 Mar;57(3):132-7. doi: 10.11622/smedj.2016054.

引用本文的文献

1
Case report: Management of liver cancer complicated by gastric varices rupture and bleeding: transjugular intrahepatic portosystemic shunt utilizing the mesenteric venous pathway.病例报告:肝癌合并胃静脉曲张破裂出血的治疗:经颈静脉肝内门体分流术采用肠系膜静脉途径
Front Med (Lausanne). 2024 Jun 19;11:1388584. doi: 10.3389/fmed.2024.1388584. eCollection 2024.
2
Analysis of Factors Influencing Prognosis and Assessment of 60 Cases of Decompensated Cirrhotic Patients with Portal Hypertension.60例失代偿期肝硬化门静脉高压患者预后影响因素分析及评估
Int J Gen Med. 2024 Apr 18;17:1493-1498. doi: 10.2147/IJGM.S453107. eCollection 2024.

本文引用的文献

1
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.卡维地洛在竞争风险荟萃分析中降低了代偿性肝硬化患者失代偿和死亡的风险。
J Hepatol. 2022 Oct;77(4):1014-1025. doi: 10.1016/j.jhep.2022.05.021. Epub 2022 May 31.
2
Update on the management of gastric varices.胃静脉曲张管理的最新进展。
Liver Int. 2022 Jun;42(6):1250-1258. doi: 10.1111/liv.15181. Epub 2022 Feb 21.
3
Baveno VII - Renewing consensus in portal hypertension.《巴韦诺 VII 共识:门静脉高压领域的新共识》
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.
4
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.非选择性β受体阻滞剂治疗应答对 NASH 肝硬化合并静脉曲张患者的预后价值。
Dig Liver Dis. 2022 Apr;54(4):500-508. doi: 10.1016/j.dld.2021.09.009. Epub 2021 Nov 16.
5
Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?非肝硬化性非酒精性脂肪性肝病中被忽视的亚临床门静脉高压:它是否真实存在,以及如何测量?
J Hepatol. 2022 Feb;76(2):458-463. doi: 10.1016/j.jhep.2021.09.029. Epub 2021 Oct 2.
6
Towards a new definition of decompensated cirrhosis.朝着一个新的失代偿性肝硬化定义迈进。
J Hepatol. 2022 Jan;76(1):202-207. doi: 10.1016/j.jhep.2021.06.018. Epub 2021 Jun 23.
7
Hepatic Venous Pressure Gradient.肝静脉压力梯度
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):144-148. doi: 10.1002/cld.1031. eCollection 2021 Mar.
8
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.PREDICT研究揭示了急性失代偿性肝硬化的三种具有不同病理生理学特征的临床病程。
J Hepatol. 2020 Oct;73(4):842-854. doi: 10.1016/j.jhep.2020.06.013. Epub 2020 Jul 13.
9
Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.代偿期肝硬化患者肝静脉压力梯度≥20mmHg 与临床失代偿及结局的关系。
Am J Gastroenterol. 2020 Oct;115(10):1624-1633. doi: 10.14309/ajg.0000000000000653.
10
A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding.基于肝硬化和 HVPG 分期的预后策略改善静脉曲张出血后的风险分层。
Hepatology. 2020 Oct;72(4):1353-1365. doi: 10.1002/hep.31125. Epub 2020 Jul 6.